Open Label,Crossover,Pilot Study to Assess the Efficacy & Safety of Perispinal Admin.of Etanercept(Enbrel) in Comb.w/Nutritional Supplements vs. Nutritional Supplements Alone in Subj. w/Mild to Mod. Alzheimer's Disease Receiving Std. Care.

Trial Profile

Open Label,Crossover,Pilot Study to Assess the Efficacy & Safety of Perispinal Admin.of Etanercept(Enbrel) in Comb.w/Nutritional Supplements vs. Nutritional Supplements Alone in Subj. w/Mild to Mod. Alzheimer's Disease Receiving Std. Care.

Completed
Phase of Trial: Phase I

Latest Information Update: 23 May 2016

At a glance

  • Drugs Etanercept (Primary) ; Curcumin; Flavins; Luteolyn; Omega 3 fatty acids; Quercetin; Resveratrol; Thioctic acid
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 May 2016 Status changed from active, no longer recruiting to completed.
    • 01 Sep 2015 Planned End Date changed from 1 Sep 2015 to 1 Dec 2015, according to ClinicalTrials.gov record.
    • 01 Sep 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Dec 2015, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top